EC Number |
Inhibitors |
Structure |
---|
2.7.7.35 | (1S)-1-(1H-benzimidazol-2-yl)-N-[(1-benzofuran-3-yl)methyl]-2-methylpropan-1-amine |
i.e. ZINC096223736, inhibitor identified by virtual screening; i.e. ZINC121003678, inhibitor identified by virtual screening, displays high number of hydrophobic contacts |
|
2.7.7.35 | (2S)-2-(1H-benzimidazol-2-yl)-N-[(3-cyclopropyl-1H-pyrazol-5-yl)methyl]pyrrolidine-1-carboxamide |
i.e. ZINC426746041, inhibitor identified by virtual screening |
|
2.7.7.35 | (5-amino-4-chloro-1H-pyrazol-3-yl)[(2S)-2-(5-fluoro-1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone |
i.e. ZINC217844024, inhibitor identified by virtual screening, displays high amount of hydrogen bonding |
|
2.7.7.35 | 2-[[(1H-benzimidazol-2-yl)methyl]sulfanyl]quinazolin-4-ol |
i.e. ZINC082673, inhibitor identified by virtual screening, displays high number of hydrophobic contacts |
|
2.7.7.35 | 4-(3-methoxypropyl)-5-[[(2S)-1-(2-methyl-3H-indol-3-yl)-1-oxopropan-2-yl]sulfanyl]-2,4-dihydro-3H-1,2,4-triazol-3-one |
i.e.ZINC014116837, inhibitor identified by virtual screening, displays high number of hydrophobic contacts |
|
2.7.7.35 | ADP |
weak, ADP-ribose phosphorolysis |
|
2.7.7.35 | ADP-ribose |
competitive to phosphate |
|
2.7.7.35 | Ag2+ |
- |
|
2.7.7.35 | AMP |
kinetics |
|
2.7.7.35 | AMP |
- |
|